Drugs / PT009
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02189304 | Jun → Sep 2014 | chronic obstructive pulmonary disease | Pearl Therapeutics, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PT009 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02189304 ↗ |
| Route | Inhaled | “PT009 administered as 2 inhalations” NCT02189304 ↗ |